SCHEMBL7991785

SCHEMBL7991785

Cc1cccc(Cn2cnc3nc(-c4ccccn4)[nH]c(=O)c32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.46
ALDH1A1 P00352 7/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
KMT2A Q03164 2/20 0.45
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
CBFB Q13951 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 2/20 0.41
AGTR1 P30556 1/20 0.41
HTT P42858 4/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991530 0.89 HPGD (0.48) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7985490 0.88 ALDH1A1 (0.56) HPGDALDH1A1SMN1; SMN2KMT2AMETAP2
SCHEMBL7992174 0.88 SMN1; SMN2 (0.48) HPGDALDH1A1SMN1; SMN2KMT2AMETAP2
SCHEMBL7974003 0.88 ALDH1A1 (0.45) HPGDALDH1A1SMN1; SMN2KMT2AMETAP2
SCHEMBL7985453 0.87 GAA (0.52) HPGDALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL7974266 0.86 ALDH1A1 (0.50) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7988745 0.84 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7991792 0.84 ALDH1A1 (0.44) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7974306 0.83 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1
SCHEMBL7985232 0.82 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed